Metformin shown to prevent long COVID across risk groups in multiple randomized trials

Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID when taken during or shortly after acute…

Continue Reading

News Source: medicalxpress.com